Skip to content

Share Buybacks at other companies

Revvity logo
RevvityRVTY
$86.5M-43.7%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$4.03B+89.4%
AbbVie logo
AbbVieABBV
$1.49B+54.9%
Medtronic logo
MedtronicMDT
$435M+58.8%
GLW
CorningGLW
$5M-83.3%

Other financials

Income statement

See full
Revenue$1.1B+7.9%
Gross profit$735.4M+8.3%
Operating income-$31.0M-117%
Net income-$77.9M-189%
EPS (diluted)-$0.40-191%

Balance sheet

See full
Cash & equivalents$139.0M+19.6%
Total debt$3.1B+15.6%
Total equity$8.2B-0.6%
Total assets$12.5B+0.6%

Cash flow

See full
Operating cash flow$182.8M+90.0%
CapEx$86.4M+10.6%
Free cash flow$96.4M+433%

Valuation

See full
Market cap$12.85B-25.7%
Enterprise value$15.78B-20.2%
P/E54.5×+12.8×
P/S-1.3×

Profitability

See full
Gross margin65.5%-1.6pp
Operating margin11.8%-7.2pp
Net margin5.6%-4.8pp
FCF margin13.5%+4.3pp

Returns & leverage

See full
Return on equity2.9%-2.3pp
Debt / equity0.4×+0.1×
Current ratio1.3×-0.8×

Where this comes from

Reported directly by The Cooper Companies, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.

The official record: The Cooper Companies, Inc.’s 10-Q, filed June 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about The Cooper Companies, Inc.'s share buybacks.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is The Cooper Companies, Inc.'s share buybacks?
The Cooper Companies, Inc. (COO) reported share buybacks of $15.5M in Q1 2026.
How has The Cooper Companies, Inc.'s share buybacks changed year-over-year?
The Cooper Companies, Inc.'s share buybacks decreased by 61.8% year-over-year, from $40.6M to $15.5M.
What does share buybacks mean?
Cash spent by the company to buy back its own shares.
How do you interpret share buybacks?
High repurchases often signal management believes the stock is undervalued or that they have excess capital to return to shareholders.
How does share buybacks compare across companies?
Standard practice for mature companies in the healthcare sector to manage share dilution.